Your session is about to expire
← Back to Search
Hybrid Physical Therapy for Osteoarthritis (RAPTOR Trial)
RAPTOR Trial Summary
This trial is testing a new way to provide rehabilitation for people with knee pain, using a combination of in-person and remote (telerehabilitation) interventions. The goal is to see if this is feasible and effective.
RAPTOR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRAPTOR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RAPTOR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with knee osteoarthritis.I have a long-term nerve condition that affects my balance or coordination.I am willing to visit the Bedford clinic for two sessions with a physical therapist.I have a condition that affects my walking or balance.I have fallen at least twice in the past year or sought medical help for a fall.I am 40 years old or older.
- Group 1: RAPTOR Physical Therapy Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scope of participants for this medical experiment?
"Yes, according to clinicaltrials.gov this trial is still enrolling patients. This research was first listed on December 20th 2021 and has recently been revised on January 6th 2022. 27 individuals are being sought by a single location for the study."
Are there still opportunities available to join this trial?
"According to the data found on clinicaltrials.gov, this particular medical trial is currently recruiting participants. It was initially posted on December 20th 2021 and last amended January 6th 2022."
What primary outcomes is this clinical trial attempting to measure?
"The primary aim of the study is to assess any Study-Related Adverse Events / Serious Adverse Events that may arise in a period of one year. Secondary objectives center around measuring functional outcomes from baseline, such as: 6 minute walk test (measuring meters walked at self-selected pace), KOOS subscale scores for pain, activities of daily living and quality of life; and 30 second chair stand tests (number of times participant can rise/sit in given time)."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger